Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 20Terminated 9Withdrawn 3Unknown 3Recruiting 1Active not recruiting 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Precancerous Conditions 1Melanoma 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × FANG vaccine × Clear all
NCT00093522 2013-12-19

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
28 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00126685 2013-09-17

Vaccine Therapy in Treating Patients With Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Dermatologic

Melanoma

NCT00002454 2011-07-26

Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

National Cancer Institute (NCI)

Phase 2 Unknown
Other neoplasm

Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡